The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Tilton John since year 2005.
The trader's CIK number is 1704251.
At the time of this reporting, Tilton John is the Chief Commercial Officer of Biohaven Pharmaceutical Holding Co Ltd. .
(stock ticker symbol BHVN).
See this page for all insider trading activities at Biohaven Pharmaceutical Holding Co Ltd. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-03-12||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Option Ex||10,000||9.29||92,899|
|2019-03-12||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Sale||10,000||50.11||501,100|
|2019-01-10||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Sale||10,500||37.67||395,535|
|2019-01-10||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Option Ex||10,500||9.29||97,544|
|2017-11-01||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Sale||30,000||29.36||880,950|
|2017-11-01||BHVN||Biohaven Pharmaceutical Holding Co Ltd.||Option Ex||30,000||9.29||278,700|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tilton John (Chief Commercial Officer of Biohaven Pharmaceutical Holding Co Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.